John T. Treace, Chief Executive Offer at TREACE MEDICAL CONCEPTS, INC. (TMCI), bought 42,982 shares at $20.95 ($900K) on 2022-08-26, disclosed to the SEC on 2022-08-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.95 | 21,491 | $450K | 50.0% |
| 2 | $20.95 | 21,491 | $450K | 50.0% |
| Total | $20.95 avg | 42,982 | $900K | 100% |
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |